Surgical and Endoscopic Therapies for GERD

Author/s: 
Sri Ganeshamurthy Thrumurthy, Yuto Shimamura, Jimmy Bok Yan So
Date Added: 
July 8, 2026
Journal/Publication: 
JAMA
Publisher: 
The American Medical Association
Publication Date: 
July 1, 2026
Type: 
Meta-analyses, Reviews, and Guidelines
Format: 
Article
DOI (1): 
doi: 10.1001/jama.2026.7636

RPR Commentary

RPR Commentary: A review of current endoscopic and surgical treatments for GERD. James W. Mold, MD, MPH

Abstract

Gastroesophageal reflux disease (GERD) affects quality of life and may cause erosive esophagitis, Barrett esophagus, and esophageal strictures and adenocarcinoma.1 The American Society for Gastrointestinal Endoscopy (ASGE) recommends initial management with behavioral modifications (eg, avoidance of meals within 3 hours of bedtime, elevating head of bed while asleep)2 prior to or combined with medications, such as proton pump inhibitors (PPIs), histamine-2 receptor antagonists, or potassium-competitive acid blockers (eg, vonoprazan). However, up to 54.1% of patients have persistent, troublesome symptoms (ie, heartburn or regurgitation for ≥2 d/wk) despite optimal medical therapy.3

Text Availability

Commercial full text (fees may apply)